Cargando…
Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma
The evolutionary trajectories of early lung adenocarcinoma (LUAD) have not been fully elucidated. We hypothesize that genomic analysis between pre-invasive and invasive components will facilitate the description of LUAD evolutionary patterns. We micro-dissect malignant pulmonary nodules (MPNs) into...
Autores principales: | Wang, Siwei, Du, Mulong, Zhang, Jingyuan, Xu, Weizhang, Yuan, Qianyu, Li, Ming, Wang, Jie, Zhu, Hongyu, Wang, Yuzhuo, Wang, Cheng, Gong, Yuhua, Wang, Xiaonan, Hu, Zhibin, Christiani, David C., Xu, Lin, Shen, Hongbing, Yin, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695730/ https://www.ncbi.nlm.nih.gov/pubmed/33247113 http://dx.doi.org/10.1038/s41467-020-19855-x |
Ejemplares similares
-
Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT‐based radiomics signature
por: Wang, Xiaoxiao, et al.
Publicado: (2019) -
Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression
por: Huang, Kexin, et al.
Publicado: (2023) -
FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma
por: Wang, Siwei, et al.
Publicado: (2021) -
Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma
por: Liu, Tongyan, et al.
Publicado: (2022) -
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
por: Wang, Sumeng, et al.
Publicado: (2021)